Capital International, Inc./CA/

Position in RPRX — Royalty Pharma plc

CIK 895213 Los Angeles, CA

Position in RPRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$60,272,334

+$11,156,811 QoQ

Shares Held

1,074,948

+5.0% QoQ

Ownership

0.187%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#56

of 641 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

Capital International, Inc./CA/ holds $249,590,047 across 7 Biotechnology names. RPRX ranks #3 (24.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	305,477	$87,051,780
2	VRTX	Vertex Pharmaceuticals Inc / Ma	164,407	$81,665,889
3	RPRX	Royalty Pharma plc This page	1,074,948	$60,272,334
4	REGN	Regeneron Pharmaceuticals, Inc.	13,154	$8,202,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	25,671	$7,727,741
6	ASND	Ascendis Pharma A/S	10,443	$2,785,356
7	CRSP	CRISPR Therapeutics AG	34,560	$1,884,902

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,272,334	1,074,948	+5.0%	Shares	Defined	2026-08-12
2026-03-31	$49,115,523	1,023,880	+38.5%	Shares	Defined	2026-05-13
2025-12-31	$28,562,108	739,185	+8.5%	Shares	Defined	2026-02-11
2025-09-30	$24,031,148	681,155	+3.0%	Shares	Defined	2025-11-13
2025-06-30	$23,835,142	661,536	+7.7%	Shares	Defined	2025-08-13
2021-09-30	$22,194,694	614,131	-26.7%	Shares	Defined	2021-11-15
2021-06-30	$34,352,653	838,074	-6.4%	Shares	Defined	2021-08-16
2021-03-31	$39,069,779	895,685	-12.9%	Shares	Defined	2021-05-14
2020-12-31	$51,460,158	1,028,175	+4.5%	Shares	Defined	2021-02-16
2020-09-30	$41,404,200	984,174	+74.9%	Shares	Defined	2020-11-13
2020-06-30	$27,314,230	562,600	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.